These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2835605)

  • 1. Interaction of cardiac glycosides with Na+,K+-ATPase.
    Wallick ET; Schwartz A
    Methods Enzymol; 1988; 156():201-13. PubMed ID: 2835605
    [No Abstract]   [Full Text] [Related]  

  • 2. Cation and cardiac glycoside binding sites of the Na,K-ATPase.
    Lingrel JB; Argüello JM; Van Huysse J; Kuntzweiler TA
    Ann N Y Acad Sci; 1997 Nov; 834():194-206. PubMed ID: 9405808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of ouabagenin and (Na+ + K+)-ATPase in the presence of Na+, Mg2+, and ATP.
    Yoda A; Yoda S
    Mol Pharmacol; 1981 Jan; 19(1):62-7. PubMed ID: 6259513
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of cardiac glycosides in heart and brain of dogs and their affinity to the (Na+ + K+)-ATPase.
    Kuhlmann J; Erdmann E; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):65-71. PubMed ID: 225683
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic comparison of cardiac glycoside interactions with Na+,K+-ATPases from skeletal and cardiac muscle and from kidney.
    Wallick ET; Pitts BJ; Lane LK; Schwartz A
    Arch Biochem Biophys; 1980 Jul; 202(2):442-9. PubMed ID: 6257168
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of cardiac glycosides with (Na+ + K+)-activated ATPase. A biochemical link to digitalis-induced inotropy.
    Hansen O
    Pharmacol Rev; 1984 Sep; 36(3):143-63. PubMed ID: 6093155
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.
    Dostanic-Larson I; Lorenz JN; Van Huysse JW; Neumann JC; Moseley AE; Lingrel JB
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R524-8. PubMed ID: 16467499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of Na,K-pump numbers and turnover in intact cells with [3H]ouabain.
    Hootman SR; Ernst SA
    Methods Enzymol; 1988; 156():213-29. PubMed ID: 2835606
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac glycoside binding to the Na/K-ATPase in the intact myocardial cell: electrophysiological measurement of chemical kinetics.
    Daut J; Rüdel R
    J Mol Cell Cardiol; 1981 Aug; 13(8):777-82. PubMed ID: 6267307
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of photolabels to probe the ouabain binding site of the (Na, K)-ATPase.
    Ruoho AE; Hall CC
    Ann N Y Acad Sci; 1980; 346():90-103. PubMed ID: 6247954
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
    Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
    Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptosin induces backbone structural changes in cardiac Na+ and K+ dependent adenosinetriphosphatase.
    Venkateswara RR; Dipak D; Banning JW; Vaidyanathan CS
    Biochem Int; 1990 Oct; 22(2):287-94. PubMed ID: 1965277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase.
    Lingrel JB
    Annu Rev Physiol; 2010; 72():395-412. PubMed ID: 20148682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 16. Affinity labeling of the digitalis-binding site.
    Rossi B; Lazdunski M
    Methods Enzymol; 1988; 156():323-33. PubMed ID: 2835616
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of Na+ pump in isolated cells.
    English LH; Schulz JT
    Methods Enzymol; 1989; 173():676-95. PubMed ID: 2550733
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of binding of Na+, K+, and Rb+ to Na+,K+-ATPase by centrifugation methods.
    Matsui H; Homareda H
    Methods Enzymol; 1988; 156():229-36. PubMed ID: 2835607
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+,K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity.
    Akera T; Temma K; Wiest SA; Brody TM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):157-65. PubMed ID: 212685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
    Brinkmann K; Linnertz H; Amler E; Lanz E; Herman P; Schoner W
    Eur J Biochem; 1997 Oct; 249(1):301-8. PubMed ID: 9363783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.